Evidences of conformational changes in class II Major Histocompatibility Complex molecules that affect the immunogenicity

Molecular Immunology

Volumn 38, Issue 9, 2002, Pages 661-667

  Neveu, Raphaële ^a   Auriault, Claude ^a,b   Angyalosi, Gerhild ^a   Georges, Bertrand ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b CNRS UMR 8527   (France)

Author keywords

Class II MHC; CLIP; Conformation; HLA DR1; Petide binding; T cell recognition

Indexed keywords

CHIMERIC PROTEIN; EPITOPE; HEMAGGLUTININ; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE DERIVATIVE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; HLA-DR1 ANTIGEN; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

MUS MUSCULUS;

EID: 0036168360     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00106-7     Document Type: Article

References (38)

1. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4
2. The MHC class II molecule I-Ag7 exists in alternate conformations that are peptide dependent
3. Binding of immunogenic peptides ti Ia histocompatibility molecules
4. Evidence for a conformational change in a class II Major Histocompatibility Complex molecule occurring in the same pH range where antigen binding is enhanced
5. Three-dimensional structure in the human class II histocompatibility antigen HLA-DR1
6. Subtle conformational changes induced in Major Histocompatibility Complex class II molecules by binding peptides
7. Specificity and promiscuity among naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size
8. Structural intermediates in the reactions of antigenic peptides with MHC molecules
9. New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library
10. Clip binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs
11. Structural diversity of human class II histocompatibility molecules induced by peptide ligands
12. An accessory peptide binding site with allosteric effect on the formation of peptide-MHC-II complexes?
13. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
14. Mice lacking MCH class II molecules
15. Major Histocompatibility Complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor
16. Increasing the potency of MHC class II-presented epitopes by linkage to Ii-Key peptide
17. Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding
18. Self-release of CLIP in peptide loading of HLA-DR molecules
19. Selective binding of bacterial toxins to Major Histocompatibility Complex class II-expressing cells is controlled by invariant chain and HLA-DM
20. Conformational changes in mouse MHC class II proteins at acidic pH
21. Supermotifs enable naatural invariant chain-derived peptides to interact with many Major Histocompatibility Complex-class II molecules
22. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1
23. Amino-terminal trimming of peptides for presentation on Major Histocompatibility Complex class II molecules
24. Conformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes
25. A role for peptide in determining MHC class II structure
26. MHC class II function preserved by low affinity peptide interactions preceding stable binding
27. Determinants of the peptide-induced conformational change in the human class II Major Histocompatibility Complex protein HLA-DR1
28. Motifs and supermotifs for MHC class II binding peptides
29. A role for MHC class II antigen processing in B cell development
30. Characterization of naturally processed antigen bound to Major Histocompatibility Complex class II molecules
31. The human class II HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide
32. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
33. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains
34. Subsets of HLA-DR1 molecules defined by SEB
35. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor
36. Interference of distinct invariant chains regions with superantigen contact area and antigenic peptide binding groove of HLA-DR1
37. Immunodominance: Intermolecular competition between MHC class II molecules by covalently linked T cell epitopes
38. A peptide variant of an arthritis-related T cell epitopes induced T cells that recognize this epitope as a synthetic peptide but not in its naturally processed form